Fresita Proteins Q2 FY27 Results: Net Profit ₹0.1 Cr, Down 75.0% YoY
Fresita Proteins Ltd reported revenue from operations of ₹0.8 Cr (-81.4% YoY) and net profit of ₹0.1 Cr (-75.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.1 Cr · -75.0% YoY
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements with these filters
Fresita Proteins Ltd reported revenue from operations of ₹0.8 Cr (-81.4% YoY) and net profit of ₹0.1 Cr (-75.0% YoY) for Q2 FY27.
Fresita Proteins fixed a Rs. 89.76 Crore rights issue at Rs. 120 per share, record date October 30, 2026. Issue closes November 26, 2026.
Fresita Proteins intimated a Rights Issue Committee meeting on October 26, 2026, to finalize its ₹90 Crore rights issue terms. No decisions have been made yet.
Fresita Proteins Limited concluded its 35th Annual General Meeting on September 30, 2026. Shareholders transacted five resolutions, including approval for borrowing and investment limits of ₹1,000 Crore each.
Sarda Proteins Limited responded to a BSE query regarding recent stock price movement. The company stated the fluctuations are driven by market forces and conditions.
Sarda Proteins Limited has changed its name to Fresita Proteins Limited, effective September 21, 2026. The name change received approval from the Ministry of Corporate Affairs and BSE.